Generic drug
Oxybate price, strengths & recalls
Oxybate has no weekly pharmacy acquisition cost. 4 manufacturers make it. Its official label last changed on March 2, 2026.
GenericOxybate price by strength
What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 500 mg/mL oral solution | Not priced this week | |||
Supply status: shortages & recalls
What people paid for Oxybate
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use SODIUM OXYBATE ORAL SOLUTION safely and effectively. See full prescribing information for SODIUM OXYBATE ORAL SOLUTION. SODIUM OXYBATE oral solution, CIIIInitial U.S. Approval: 2002
WARNING: CENTRAL NERVOUS SYSTEM (CNS) DEPRESSION and ABUSE AND MISUSE.
Central Nervous System Depression
Sodium oxybate oral solution is a CNS depressant. In clinical trials at recommended doses, obtundation and clinically significant respiratory depression occurred in adult patients treated with sodium oxybate oral solution [see Warnings and Precautions (5.1)]. Many patients who received sodium oxybate oral solution during clinical trials in narcolepsy were receiving central nervous system stimulants [see Clinical Trials (14)].
Abuse and Misuse
Sodium oxybate oral solution is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB, either alone or in combination with other CNS depressants, is associated with CNS adverse reactions, including seizure, respiratory depression, decreases in the level of consciousness, coma, and death [see Warnings and Precautions (5.2)].
Because of the risks of CNS depression and abuse and misuse, sodium oxybate oral solution is available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Sodium Oxybate REMS Program [see Warnings and Precautions (5.3)].
WARNING: CENTRAL NERVOUS SYSTEM (CNS) DEPRESSION and ABUSE AND MISUSE.
See full prescribing information for complete boxed warning.
Central Nervous System Depression
Sodium oxybate oral solution is a CNS depressant, and respiratory depression can occur with sodium oxybate oral solution use (5.1, 5.4)
Abuse and Misuse
Sodium oxybate oral solution is the sodium salt of gamma-hydroxybutyrate (GHB). Abuse or misuse of illicit GHB is associated with CNS adverse reactions, including seizure, respiratory depression, decreased consciousness, coma, and death (5.2, 9.2)
Sodium oxybate oral solution is available only through a restricted program called the Sodium Oxybate REMS Program (5.3)
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA021196 · Jazz Pharms
- First approved
- July 17, 2002 (24 years ago)
- Latest approved change
- July 28, 2025
- Approved label
- PDF, Apr 10, 2023
- Generic makers
- 2 approved generic applications on the market
- Last patent listed
- September 15, 2033
- Exclusivity ends
- April 26, 2026 (ended)
Oxybate questions
Is oxybate in shortage?
No shortage is reported for oxybate right now. We check the national shortage list every day.
Has oxybate been recalled?
No recalls are on record for oxybate.
When did the oxybate label last change?
The official label was last updated on March 2, 2026 (version 19). See what changed.
Talk about oxybate
No comments yet. Questions, tips, what worked for you - start the conversation.